Diabetic Complications Neurological

1

Review clinical trials related to Diabetic Complications Neurological. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Is Serum Irisin Level a Biomarker in Diabetic Polyneuropathy?

Diabetic polyneuropathy is a common complication of type 2 diabetes mellitus associated with sensory impairment and functional disability. Irisin is a myokine that has been implicated in glucose metabolism and neuroprotection. This prospective observational case-control study aims to evaluate serum irisin concentrations in patients with diabetic polyneuropathy compared with diabetic patients without neuropathy and healthy controls, and to investigate whether serum irisin may serve as a biomarker for diabetic polyneuropathy.

Participants needed: 81
Trial details
Age: 30-75Biological sex: AllType: ObservationalSponsor: GÜLDEN ANATACAUpdated: Jul 29, 2026Locations: 1Duration: 12 Weeks
Eligibility criteria

Age between 30 and 75 years [+3]

Neuropathy due to causes other than diabetes (e.g., vitamin B12 deficiency, chro... [+6]